Supreme Court · 2017 INSC 1248 · Decided 15 December 2017
Union of India and ANR. v. Pfizer Limited and ORS.
- Court
- Supreme Court of India
- Citation
- 2017 INSC 1248 · [2017] 12 S.C.R. 179
- Case number
- CIVIL APPEAL No. 22972/2017
- Decided
- 15 December 2017
- Bench
- R.F. NARIMAN, SANJAY KISHAN KAUL (2-judge bench)
- Outcome
- Disposed off
- Case type
- Civil
Headnote
Drugs and Cosmetics Act, 1940 - s. 26A - Powers of Central A B . Government to prohibit manufacture, etc., of drug and cosmetic in public interest - Exercise of - Prior consultation with Drugs Technical Advisory Board (DTAB) set up u/s. 5 - Mandatory or not c - Held: s. 26A is an additional power by its own terms - Section 26A has to be read with the rest of the Drugs Act - Unlike s. 6(2), s. 8(2), second proviso to s. JO, proviso to s. 12( I), s. 16(2), proviso to s. 18(2), s. 33 ands. 33N, there is no explicit requirement to consult the DTAB set up u/s. 5 - Section 26A was brought in
Judgments are the courts' own published copies, provided for study; they are not certified copies. Source: Indian Supreme Court & High Court Judgments, Dattam Labs (CC-BY-4.0)